
The innovations helping women navigate and better understand menopause are to be recognised in the first-ever Femtech World Awards.
The inaugural Femtech World Awards will shine a spotlight on the organisations driving innovation in women’s health.
The Menopause Innovation award will give recognition to those working in the menopause sector whose work and dedication are shaping the future of healthcare.
Sponsored by the AI fertility company Fairtility, the award is one of 10 categories open for entry in the Femtech World Awards, which seek to support the next wave of innovation in women’s health and recognise the outstanding commitment to improving patient outcomes.
Fairtility is advancing reproductive care through the power of transparent AI to help clinicians and their patients on the reproductive care journey.
The company believes that transparency is critical when AI intersects with human life. Its flagship software, CHLOE, is a transparent AI-based decision support tool providing clinicians with visibility into clinical and laboratory parameters crucial to improving reproductive care outcomes in IVF, fertility preservation and egg donation.
Eran Eshed, co-founder and CEO of Fairtility, said: “Fairtility is honoured to be part of the Menopause Innovation award, recognising the need for progressive solutions in women’s health.
“Menopause affects half of the population, yet the conversation surrounding it is often shrouded in misconceptions. By sponsoring this category, we aim to support groundbreaking innovations that will contribute to a brighter, more informed future for women worldwide.”
Sorina Mihaila, editor of Femtech World, said: “Although virtually all women experience menopause, it remains a highly stigmatised topic.
“Our aim is to tackle some of that stigma by celebrating the life-changing innovations in this space.”
Find out more about the awards and enter for free here.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









